Remco A. Koster

1.9k total citations
40 papers, 1.5k citations indexed

About

Remco A. Koster is a scholar working on Immunology, Pharmacology and Hematology. According to data from OpenAlex, Remco A. Koster has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 17 papers in Pharmacology and 12 papers in Hematology. Recurrent topics in Remco A. Koster's work include Biosimilars and Bioanalytical Methods (22 papers), Antibiotics Pharmacokinetics and Efficacy (16 papers) and Erythropoietin and Anemia Treatment (9 papers). Remco A. Koster is often cited by papers focused on Biosimilars and Bioanalytical Methods (22 papers), Antibiotics Pharmacokinetics and Efficacy (16 papers) and Erythropoietin and Anemia Treatment (9 papers). Remco A. Koster collaborates with scholars based in Netherlands, United States and Vietnam. Remco A. Koster's co-authors include Jan‐Willem C. Alffenaar, Donald R. A. Uges, Daan J. Touw, Ben Greijdanus, Herman Veenhof, Dinh Hoa Vu, Eli Dijkers, J. R. B. J. Brouwers, Stefan P. Berger and Stephan J. L. Bakker and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Remco A. Koster

40 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Remco A. Koster Netherlands 21 730 524 311 278 271 40 1.5k
Leo Stolk Netherlands 23 831 1.1× 623 1.2× 434 1.4× 261 0.9× 216 0.8× 68 2.4k
Ben Greijdanus Netherlands 21 326 0.4× 396 0.8× 82 0.3× 116 0.4× 287 1.1× 37 1.2k
Sara Capiau Belgium 10 657 0.9× 183 0.3× 60 0.2× 218 0.8× 57 0.2× 13 930
Yves Théorêt Canada 23 171 0.2× 244 0.5× 135 0.4× 442 1.6× 140 0.5× 111 2.8k
Anton Pohanka Sweden 23 165 0.2× 193 0.4× 65 0.2× 68 0.2× 108 0.4× 51 1.2k
Jessica Cusato Italy 27 142 0.2× 370 0.7× 44 0.1× 133 0.5× 1.1k 4.0× 164 2.6k
Franck Saint‐Marcoux France 29 72 0.1× 248 0.5× 802 2.6× 93 0.3× 182 0.7× 101 2.0k
Mingkang Zhong China 25 102 0.1× 241 0.5× 231 0.7× 34 0.1× 120 0.4× 100 1.7k
Gary L. Lensmeyer United States 20 209 0.3× 172 0.3× 150 0.5× 29 0.1× 69 0.3× 37 1.6k
Adam Frymoyer United States 26 85 0.1× 583 1.1× 32 0.1× 123 0.4× 519 1.9× 80 2.3k

Countries citing papers authored by Remco A. Koster

Since Specialization
Citations

This map shows the geographic impact of Remco A. Koster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Remco A. Koster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Remco A. Koster more than expected).

Fields of papers citing papers by Remco A. Koster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Remco A. Koster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Remco A. Koster. The network helps show where Remco A. Koster may publish in the future.

Co-authorship network of co-authors of Remco A. Koster

This figure shows the co-authorship network connecting the top 25 collaborators of Remco A. Koster. A scholar is included among the top collaborators of Remco A. Koster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Remco A. Koster. Remco A. Koster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gerding, Albert, Stijn J.H. Waaijer, Remco A. Koster, et al.. (2024). Everolimus decreases [U-13C]glucose utilization by pyruvate carboxylase in breast cancer cells in vitro and in vivo. Biomedicine & Pharmacotherapy. 173. 116362–116362. 1 indexed citations
2.
Veenhof, Herman, et al.. (2022). Results From a Proficiency Testing Pilot for Immunosuppressant Microsampling Assays. Therapeutic Drug Monitoring. 45(1). 61–68. 12 indexed citations
3.
Sturkenboom, Marieke G. G., Samiksha Ghimire, Onno W. Akkerman, et al.. (2018). Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs. PubMed. 14. 34–45. 18 indexed citations
4.
Boonstra, J., et al.. (2018). Simple and Robust LC–MS/MS Analysis Method for Therapeutic Drug Monitoring of Micafungin. Bioanalysis. 10(11). 877–886. 10 indexed citations
5.
Boonstra, J., Anette Veringa, Roger J. M. Brüggemann, et al.. (2017). Pharmacokinetic Properties of Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis. Antimicrobial Agents and Chemotherapy. 61(12). 33 indexed citations
6.
Buiten, Azuwerus van, et al.. (2017). The Novel Compound Sul-121 Preserves Endothelial Function and Inhibits Progression of Kidney Damage in Type 2 Diabetes Mellitus in Mice. Scientific Reports. 7(1). 11165–11165. 14 indexed citations
7.
Cohen, Dan, Kai van Hateren, Remco A. Koster, et al.. (2017). Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Clozapine. The Journal of Clinical Psychiatry. 78(9). e1211–e1218. 24 indexed citations
8.
Koster, Remco A., Herman Veenhof, Stefan P. Berger, et al.. (2017). Dried Blood Spot Validation of Five Immunosuppressants, Without Hematocrit Correction, on Two LC–MS/MS Systems. Bioanalysis. 9(7). 553–563. 43 indexed citations
9.
Veenhof, Herman, Remco A. Koster, Jan‐Willem C. Alffenaar, et al.. (2016). Clinical Validation of Simultaneous Analysis of Tacrolimus, Cyclosporine A, and Creatinine in Dried Blood Spots in Kidney Transplant Patients. Transplantation. 101(7). 1727–1733. 55 indexed citations
10.
VanDerNagel, Joanne, Robert Didden, Hubert Korzilius, et al.. (2016). Substance use in individuals with mild to borderline intellectual disability: A comparison between self-report, collateral-report and biomarker analysis. Research in Developmental Disabilities. 63. 151–159. 16 indexed citations
11.
Veringa, Anette, Marieke G. G. Sturkenboom, Bart G. J. Dekkers, et al.. (2016). LC-MS/MS for Therapeutic Drug Monitoring of anti-infective drugs. TrAC Trends in Analytical Chemistry. 84. 34–40. 37 indexed citations
12.
Koster, Remco A., Hugo Vereecke, Ben Greijdanus, et al.. (2015). Analysis of Remifentanil with Liquid Chromatography-Tandem Mass Spectrometry and an Extensive Stability Investigation in EDTA Whole Blood and Acidified EDTA Plasma. Anesthesia & Analgesia. 120(6). 1235–1241. 17 indexed citations
13.
Vu, Dinh Hoa, Remco A. Koster, Mathieu S. Bolhuis, et al.. (2014). Simultaneous determination of rifampicin, clarithromycin and their metabolites in dried blood spots using LC–MS/MS. Talanta. 121. 9–17. 69 indexed citations
14.
Koster, Remco A., Ben Greijdanus, Jan‐Willem C. Alffenaar, & Daan J. Touw. (2014). Dried blood spot analysis of creatinine with LC-MS/MS in addition to immunosuppressants analysis. Analytical and Bioanalytical Chemistry. 407(6). 1585–1594. 47 indexed citations
15.
Vu, Dinh Hoa, Remco A. Koster, A. Mireille A. Wessels, et al.. (2013). Troubleshooting carry-over of LC–MS/MS method for rifampicin, clarithromycin and metabolites in human plasma. Journal of Chromatography B. 917-918. 1–4. 31 indexed citations
16.
Koster, Remco A., Jan‐Willem C. Alffenaar, Ben Greijdanus, Joanne VanDerNagel, & Donald R. A. Uges. (2013). Fast and Highly Selective LC-MS/MS Screening for THC and 16 Other Abused Drugs and Metabolites in Human Hair to Monitor Patients for Drug Abuse. Therapeutic Drug Monitoring. 36(2). 234–243. 38 indexed citations
17.
Koster, Remco A., Jan‐Willem C. Alffenaar, Ben Greijdanus, & Donald R. A. Uges. (2013). Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery. Talanta. 115. 47–54. 111 indexed citations
18.
Koster, Remco A., Jan‐Willem C. Alffenaar, Ben Greijdanus, Joanne VanDerNagel, & Donald R. A. Uges. (2013). Application of Sweat Patch Screening for 16 Drugs and Metabolites Using a Fast and Highly Selective LC-MS/MS Method. Therapeutic Drug Monitoring. 36(1). 35–45. 28 indexed citations
19.
Vu, Dinh Hoa, Remco A. Koster, Jan‐Willem C. Alffenaar, J. R. B. J. Brouwers, & Donald R. A. Uges. (2011). Determination of moxifloxacin in dried blood spots using LC–MS/MS and the impact of the hematocrit and blood volume. Journal of Chromatography B. 879(15-16). 1063–1070. 113 indexed citations
20.
Koster, Remco A., Eli Dijkers, & Donald R. A. Uges. (2009). Robust, High-Throughput LC-MS/MS Method for Therapeutic Drug Monitoring of Cyclosporine, Tacrolimus, Everolimus, and Sirolimus in Whole Blood. Therapeutic Drug Monitoring. 31(1). 116–125. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026